Metabolic syndrome among patients taking second generation antipsychotics: does obstructive sleep apnoea and sleep quality play any role?
Background: Metabolic syndrome (MetS) is common among patients who have been exposed to second generation antipsychotics (SGA). Obstructive sleep apnoea (OSA) and sleep quality may also contribute to MetS. Aims: To study the contribution of sleep quality and OSA on the development of MetS in patient...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy Publisher
2020-04-01
|
Series: | Open Journal of Psychiatry and Allied Sciences |
Subjects: | |
Online Access: | https://www.ojpas.com/get_file.php?id=33984016&vnr=372186 |